Acute ischaemic stroke treated with combined intra-arterial thrombolysis and intravenous tirofiban despite oral anticoagulant therapy at an international normalised ratio >-2.0
- 1 September 2006
- journal article
- Published by Springer Nature in Internal and Emergency Medicine
- Vol. 1 (3) , 250-252
- https://doi.org/10.1007/bf02934752
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Trial Design and Reporting Standards for Intra-Arterial Cerebral Thrombolysis for Acute Ischemic StrokeStroke, 2003
- Acute Basilar Artery Occlusion Treated With Combined Intravenous Abciximab and Intra-arterial Tissue Plasminogen ActivatorStroke, 2002
- Combined Direct Percutaneous Transluminal Angioplasty and Low-Dose Native Tissue Plasminogen Activator Therapy for Acute Embolic Middle Cerebral Artery Trunk Occlusion2002
- Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: the GUSTO V randomised trialThe Lancet, 2001
- Abciximab in Acute Ischemic StrokeStroke, 2000
- The Platelet IIb/IIIa Inhibitor Abciximab as Adjunctive Therapy in Carotid Stenting of Potential Thrombotic LesionsJournal of Interventional Cardiology, 1999